13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
105 檔
19.1%
At the close of Q3 2024, Simplify Asset Management Inc. disclosed equity holdings valued at approximately $7.2B, spread across 105 reported holdings.
In Q3 2024, Simplify Asset Management Inc. displayed an active expansion posture, initiating 13 new positions and adding to 17 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | ETF-Commodities | 26.14% | +0.57% | NEW | |
| 2 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 20.00% | -0.08% | +5.98% | |
| 3 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 6.65% | +0.69% | -16.71% | |
| 4 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 5.85% | — | — | |
| 5 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 5.25% | -0.07% | +6.06% | |
| 6 | BUCK | Simplify Treasury Option Inc | ETF-Gov Bonds | 5.09% | -0.06% | +38.32% | |
| 7 | NMB | Simplify National Muni Bnd | ETF-Other | 3.67% | -0.04% | — | |
| 8 | TYA | Simplify Intermediate Term | ETF-Other | 2.59% | — | +14248.35% | |
| 9 | MTBA | Simplify Mbs ETF | ETF-Other | 2.58% | — | +21.56% | |
| 10 | SCHP | Schwab U.s. Tips ETF | ETF-Other | 1.78% | — | +17.30% | |
| 11 | CDX | Simplify High Yield ETF | ETF-High Yield | 1.52% | — | -66.02% | |
| 12 | MINT | Pimco Enhanced Short Maturit | ETF-Other | 1.18% | — | — | |
| 13 | JPST | Jpmorgan Ultra-short Income | ETF-Other | 1.17% | — | — | |
| 14 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.12% | — | +84.64% | |
| 15 | APLT | Applied Therapeutics Inc | Stock-Other | 1.12% | — | — | |
| 16 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 1.10% | -0.04% | -7.29% | |
| 17 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.79% | +0.01% | +67.21% | |
| 18 | PCT | Purecycle Technologies Inc | Stock-Other | 0.78% | +0.20% | +67.43% | |
| 19 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.55% | +0.23% | +49.79% | |
| 20 | SNY | Sanofi-adr | Stock-Healthcare | 0.55% | — | — | |
| 21 | ZTS | Zoetis Inc | Stock-Healthcare | 0.54% | — | — | |
| 22 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.53% | -0.04% | +51.45% | |
| 23 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.51% | +0.14% | +187.42% | |
| 24 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.47% | -0.13% | EXIT | |
| 25 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.44% | — | — | |
| 26 | ABBV | Abbvie Inc | Stock-Healthcare | 0.43% | +0.07% | — | |
| 27 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.40% | +0.03% | +67.44% | |
| 28 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.38% | — | +15.59% | |
| 29 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.38% | +0.01% | — | |
| 30 | CI | THE Cigna Group | Stock-Healthcare | 0.34% | — | +328.25% | |
| 31 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.27% | — | — | |
| 32 | MMM | 3m Co | Stock-Industrials | 0.25% | -0.10% | EXIT | |
| 33 | CHWY | Chewy Inc - Class A | Stock-Consumer Disc | 0.25% | — | — | |
| 34 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.24% | — | — | |
| 35 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.23% | — | -0.03% | |
| 36 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 0.23% | — | — | |
| 37 | TSAT | Telesat CORP | Stock-Other | 0.22% | — | — | |
| 38 | TFX | Teleflex Inc | Stock-Healthcare | 0.22% | — | — | |
| 39 | MYGN | Myriad Genetics Inc | Stock-Other | 0.22% | — | — | |
| 40 | ARDX | Ardelyx Inc | Stock-Other | 0.22% | — | +15.28% | |
| 41 | ELV | Elevance Health Inc | Stock-Healthcare | 0.21% | +0.14% | NEW | |
| 42 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.20% | — | — | |
| 43 | TUA | Sim St Treas Fut Strat ETF | ETF-Other | 0.18% | -0.42% | +63.11% | |
| 44 | RVTY | Revvity Inc | Stock-Healthcare | 0.14% | — | -5.70% | |
| 45 | CYPH | Cypherpunk Technologies Inc | Stock-Other | 0.13% | — | +67.42% | |
| 46 | RPRX | Royalty Pharma plc | Stock-Healthcare | 0.12% | — | +67.41% | |
| 47 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.12% | — | — | |
| 48 | NLY | Annaly Capital Management In | Stock-Real Estate | 0.12% | — | +32.30% | |
| 49 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.11% | — | +62.50% | |
| 50 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 0.11% | — | +67.80% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | +26.1% | NEW | New buy |
| 2 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | +5.9% | NEW | New buy |
| 3 | NMB | Simplify National Muni Bnd | +3.7% | NEW | New buy |
| 4 | TYA | Simplify Intermediate Term | +2.6% | +14248.35% | Add |
| 5 | MINT | Pimco Enhanced Short Maturit | +1.2% | NEW | New buy |
| 6 | JPST | Jpmorgan Ultra-short Income | +1.2% | NEW | New buy |
| 7 | SNY | Sanofi-adr | +0.6% | NEW | New buy |
| 8 | ZTS | Zoetis Inc | +0.5% | NEW | New buy |
| 9 | ABBV | Abbvie Inc | +0.4% | NEW | New buy |
| 10 | GILD | Gilead Sciences Inc | +0.4% | NEW | New buy |
| 11 | PCT | Purecycle Technologies Inc | +0.4% | +67.43% | Add |
| 12 | JNJ | Johnson & Johnson | +0.3% | +187.42% | Add |
| 13 | CHWY | Chewy Inc - Class A | +0.3% | NEW | New buy |
| 14 | APLT | Applied Therapeutics Inc | +0.2% | — | Unchanged |
| 15 | CI | THE Cigna Group | +0.2% | +328.25% | Add |
| 16 | TNDM | Tandem Diabetes Care Inc | +0.2% | NEW | New buy |
| 17 | TFX | Teleflex Inc | +0.2% | NEW | New buy |
| 18 | MYGN | Myriad Genetics Inc | +0.2% | NEW | New buy |
| 19 | LLY | Eli Lilly & Co | +0.1% | +67.21% | Add |
| 20 | TMO | Thermo Fisher Scientific Inc | +0.1% | +67.44% | Add |
| 21 | UNH | Unitedhealth Group Inc | +0.1% | +49.79% | Add |
| 22 | PHAT | Phathom Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 23 | ISRG | Intuitive Surgical Inc | +0.1% | +51.45% | Add |
| 24 | REGN | Regeneron Pharmaceuticals | 0% | +50.80% | Add |
| 25 | SRPT | Sarepta Therapeutics Inc | 0% | +84.64% | Add |
| 26 | MMM | 3m Co | 0% | +13.15% | Add |
| 27 | AKRO | Akero Therapeutics Inc | 0% | +15.59% | Add |
| 28 | HUM | Humana Inc | -0.1% | EXIT | Sold out |
| 29 | MASI* | Masimo CORP | -0.2% | EXIT | Sold out |
| 30 | NBIX | Neurocrine Biosciences Inc | -0.2% | EXIT | Sold out |
| 31 | BUCK | Simplify Treasury Option Inc | -0.2% | +38.32% | Add |
| 32 | FULC | Fulcrum Therapeutics Inc | -0.2% | -47.94% | Trim |
| 33 | ✓ | Athira Pharma Inc | -0.2% | — | Unchanged |
| 34 | SCHP | Schwab U.s. Tips ETF | -0.3% | +17.30% | Add |
| 35 | NVO | Novo-nordisk A/s-spons Adr | -0.4% | EXIT | Sold out |
| 36 | MTBA | Simplify Mbs ETF | -0.4% | +21.56% | Add |
| 37 | BSX | Boston Scientific CORP | -0.4% | EXIT | Sold out |
| 38 | MRK | Merck & Co. Inc. | -0.4% | EXIT | Sold out |
| 39 | PAGP | Plains Gp Holdings Lp-cl A | -0.6% | -7.29% | Trim |
| 40 | AGGH | Simplify Aggregate Bond ETF | -1.6% | +6.06% | Add |
| 41 | CVNA | Carvana Co | -1.6% | EXIT | Sold out |
| 42 | KRE | Ss Spdr S&p Regional Bank | -1.6% | EXIT | Sold out |
| 43 | XOP | Ss Spdr S&p Og Exp & Prod | -1.7% | EXIT | Sold out |
| 44 | XLE | Ss Energy Select Sector | -1.8% | EXIT | Sold out |
| 45 | AGG | Ishares Core U.s. Aggregate | -4.4% | -16.71% | Trim |
| 46 | SLV | Ishares Silver Trust | -4.7% | EXIT | Sold out |
| 47 | CDX | Simplify High Yield ETF | -4.7% | -66.02% | Trim |
| 48 | EFA | Ishares Msci Eafe ETF | -5.1% | EXIT | Sold out |
| 49 | IVV | Ishares Core S&p 500 ETF | -5.8% | +5.98% | Add |
| 50 | ITB | Ishares U.s. Home Constructi | -7% | EXIT | Sold out |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 105 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GLD, IVV, AGG) accounted for 19.1% of total reported equity market value during Q3 2024.
Top New Position Initiated
GLD
市值: $561.2M
Top Position Liquidated / Trimmed
ITB
前期市值: $104.5M
During Q3 2024, Simplify Asset Management Inc.'s top holdings by market value included GLD (26.1%)、IVV (20.0%)、AGG (6.7%). The largest single position, GLD, represented 26.1% of total portfolio value.
In Q3 2024, Simplify Asset Management Inc. made 47 total portfolio adjustments, initiating 13 new buys, adding to 17 positions, trimming 4 holdings, and fully liquidating 13 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.